Video Experimental Relacionado
Updated: Apr 13, 2026
08:46
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
11.3K
Información genética, tecnologías genómicas y el futuro del descubrimiento de fármacos
1Research Technologies and Proteins (DC0444), Lilly Research Laboratories, A Division of Eli Lilly and Co, Lilly Corporate Center, Indianapolis, IN 46285, USA. bumol@lilly.com
JAMA
|February 15, 2001
Resumen
El proyecto del genoma humano permite comprender la genética de las enfermedades. Las nuevas tecnologías como el perfil de transcripción ayudan al descubrimiento de fármacos mediante la identificación de objetivos moleculares para futuros productos farmacéuticos.
Área de la Ciencia:
- La genómica es la genómica.
- Biología Molecular Biología Molecular
- Farmacología Farmacología.
Sus antecedentes:
- El proyecto del genoma humano proporciona una base para comprender las enfermedades genéticas.
- Los avances en tecnologías biológicas, incluido el perfil de transcripción, ofrecen análisis moleculares de alta resolución.
- El descubrimiento actual de fármacos se centra en la identificación y validación de objetivos dentro de las vías moleculares.
Objetivo del estudio:
- Aprovechar la información genómica y las nuevas tecnologías para la investigación de enfermedades.
- Para identificar y validar objetivos farmacéuticos en sistemas moleculares.
- Desarrollar y evaluar nuevas intervenciones terapéuticas.
Principales métodos:
- Utilizando el primer borrador de la secuencia del genoma humano.
- Empleando tecnologías biológicas avanzadas como el perfil de transcripción.
- Analizar las vías y sistemas moleculares para la identificación de objetivos.
Principales resultados:
- Una oportunidad sin precedentes para entender la base genética de la enfermedad.
- Capacidad para examinar sistemas biológicos a alta resolución molecular.
- Identificación de objetivos farmacéuticos potenciales.
Conclusiones:
- Los conocimientos genómicos y los avances tecnológicos están impulsando la innovación farmacéutica.
- Nuevas intervenciones terapéuticas están surgiendo de esta investigación.
- Este trabajo constituye la base para futuros productos farmacéuticos innovadores.
Más Videos Relacionados
Videos de Conceptos Relacionados
03:00Next-generation Sequencing
101.9K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
101.9K
01:26Drug Discovery: Overview
13.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.5K
01:29Pharmacogenetics and Pharmacogenomics: Overview
180
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
180
01:27Principles of Pharmacogenetics: Types of Genetic Variants
113
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
113
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
126
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
126
01:29Pharmacogenomics: Identification of New Drug Targets
92
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
92